Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected]
- PMID: 7584668
- DOI: 10.1089/jir.1995.15.231
Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected]
Erratum in
- J Interferon Cytokine Res 1995 Sep;15(9):828
Abstract
The antiviral activity of human r-metIFN-con1 was compared with that of IFN-alpha 2b and IFN-beta on a number of human, other primate, rodent, feline, and canine cell lines. Although the specific activities of r-metIFN-con1 and IFN-alpha 2b differed 10-fold, the host range was very similar. The host range of IFN-beta differed from that of r-metIFN-con1 and IFN-alpha 2b in that Vero cells were 100-fold better protected by IFN-beta and MDBK protected at a 100-fold less efficiency. In general, there were only minor differences between the host ranges of the three interferons, human and primate cells being better protected than those of other species. However, the tissue of origin of the cell appears to be more important than the species of origin in defining host range [corrected].
Similar articles
-
A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.J Interferon Res. 1992 Feb;12(1):55-9. doi: 10.1089/jir.1992.12.55. J Interferon Res. 1992. PMID: 1573283
-
Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist.J Interferon Cytokine Res. 1995 Apr;15(4):317-21. doi: 10.1089/jir.1995.15.317. J Interferon Cytokine Res. 1995. PMID: 7627806
-
Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.Antiviral Res. 2007 Feb;73(2):118-25. doi: 10.1016/j.antiviral.2006.08.005. Epub 2006 Sep 11. Antiviral Res. 2007. PMID: 16987555
-
Biologic activities of natural and synthetic type I interferons.Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-63-S9-69. Semin Oncol. 1997. PMID: 9208874 Review.
-
Wherefore interferon?J Leukoc Biol. 1997 May;61(5):567-74. doi: 10.1002/jlb.61.5.567. J Leukoc Biol. 1997. PMID: 9129205 Review.
Cited by
-
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection.Antimicrob Agents Chemother. 2005 Jun;49(6):2378-86. doi: 10.1128/AAC.49.6.2378-2386.2005. Antimicrob Agents Chemother. 2005. PMID: 15917537 Free PMC article.
-
Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4513-8. doi: 10.1073/pnas.93.9.4513. Proc Natl Acad Sci U S A. 1996. PMID: 8633100 Free PMC article.
-
Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.Antiviral Res. 2007 Feb;73(2):140-6. doi: 10.1016/j.antiviral.2006.08.008. Epub 2006 Sep 22. Antiviral Res. 2007. PMID: 17049380 Free PMC article.
-
Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.Dig Dis Sci. 2011 Oct;56(10):3032-7. doi: 10.1007/s10620-011-1869-6. Epub 2011 Aug 31. Dig Dis Sci. 2011. PMID: 21879283 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous